INTRODUCTION
Cholera is an infectious disease whose course can vary from a mild diarrheal syndrome to a rapidly fatal malady (cholera gravis) characterized by the sudden onset of profuse watery diarrhea with volume depletion, metabolic acidosis, and ultimately death from hypovolemic shock. The disease is caused by Vibrio cholerae, a short, curved, bacterium that produces an enterotoxin (choleragen). Humans are the only known host for cholera vibrios [1] , which can spread rapidly though a community primarily via fecal contamination of drinking water.
Throughout its history, cholera caused widespread panic because it can afflict an otherwise healthy person without warning and lead to death in as little as four to six c To whom all correspondence should be addressed: Alan S. Segal, M.D., University of Vermont, Ion Channel Facility, 208 South Park Drive, Suite 2, Colchester, VT 05446. Tel.: 802-656-8916; Fax: 802-656-8914; E-mail: asegal@zoo.uvm.edu d Abbreviations: Ace, accessory cholera enterotoxin; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulator; CTX, cholera toxin; KATP, ATP-sensitive K+; ORT, oral rehydration therapy; tcpA, toxin regulated pili, Zot, zonula occludens toxin. Received: April 10, 1997; Accepted: March 28, 2000 393 hours. Many victims have awoken with uncompromised health at the edge of the day and died gruesomely in their own dejecta before night's retum. More recently in several parts of the world, cholera pandemics have claimed thousands of lives in outbreaks in southern Africa and Latin America. We will present three case scenarios based on actual patients illustrating many of the clinical manifestations of cholera. These will be used as a springboard to review 1) the colorful history of cholera including its impact on the origin of intravenous solution therapy, 2) the fundamental physiological principles that underlie the disease and its treatment, and 3) how aspects of cholera have intertwined with developments in modern science.
CHOLERA: SYMPTOMS, SIGNS, AND THE ORIGIN OF INTRA-VENOUS THERAPY
Case Scenario 1: Sunderland, Britain, 1831 [2] A 25-year-old woman was found in grave distress. The patient was too lethargic to provide a history, but a friend states that she was in her usual state of good health until 24 hours previously when she developed the acute onset of profuse watery diarrhea, vomiting, and muscle cramps. The villagers had collected all of her diarrheal fluid in a canister kept near the patient, since they believed that part of the reason she was so ill was that her body had been depleted of vital substances contained in the excretions. No other history was available except that several other villagers had already died from this type of illness. The first death in Sunderland had been on Oct. 26, 1831. On physical examination, the patient was extremely weak and lethargic. The silver-bluish color of her skin was reminiscent of lead. She was cool to the touch and had poor skin turgor. The wrinkled skin on her hands appeared as if it had been immersed in water for a prolonged time ("washerwomen's hands"). Her facial features were flattened and her eyes were sunk deep into their sockets. A radial pulse was not palpable, but a heart rate of 160 per minute was assessed by listening over the chest. The patient's breathing was labored, at a rate of 32 breaths per minute (hyperventilation in response to metabolic acidosis), but breath sounds over the lung fields were clear. The abdomen was soft. The extremities were cold and there was no peripheral edema.
Inspection of the canister showed approximately ten liters of nearly odorless watery fluid containing flecks of mucus ("rice-water" stools). Sensing the gravity of the patient's condition, the apothecary boiled eight gallons (30 liters) of water and prepared two solutions:
Solution #1: 5 gallons (-19 liters) of a solution containing by weight 9 parts sodium chloride to 1000 parts water (0.9% isotonic NaCl). Solution #2: 3 gallons (-11 liters) of a solution containing 12.6 parts soda of bicarbonate to 1000 parts water (isotonic bicarbonate solution).
As the patient was sinking towards death, and as the bewildered townspeople looked on, a hollow silver needle (designed by John Read [3] ) was placed in the right femoral vein and attached to a breast pump syringe by a flexible tube fashioned from goose trachea. A quart of the NaCl solution was injected over fifteen minutes, followed by a pint of the NaHCO3 solution over the next fifteen minutes. Three parts potassium chloride was also added to 1000 parts Solution #1
(KCI 40 meq/l) in a few quarts. After five cycles of this treatment, to the astonishment of all who had gathered, the patient became alert and animated. Her radial pulse returned at a rate of 112 per minute. The two solutions were continued, in alternating fashion, until the patient stated that her bladder was full. By that time she had received eight quarts of the NaCl solution (four containing KCI) and eight pints of the NaHCO3 solution, a total of over eleven liters.
The patient continued to pass "ricewater" stools and required sixteen liters of intravenous solution therapy the next day ( Figure 1 ). By the fifth day, the diarrhea had significantly decreased, but the patient had not passed any urine since day three. Despite the valiant intravenous solution replacement therapy, the patient died of progressive renal failure on day twenty [4] Hospital Day Figure 1 . Chart of the total input, total output, and stool output for the patient described in case scenario one. Note that stool accounts for nearly all the output throughout the hospital course, and that initial stool output approached ten liters per day. The patient died of oliguric renal failure on hospital day 20.
hours of intravenous therapy with Dhaka solution [6] : [Na] 133 mmol/l, [ 111 Immol/l (to facilitate Na-glucose cotransport), for a total osmolarity of 31 1 mosmll. The patient was given a volume of WHO-OHS equivalent to the total stool/emesis output, collected in graduated containers beneath a cholera cot. The patient was also given free access to food and water.
The total stool output in the first day was over 12 1, but the total output over the next two days was 4.21. The patient's diarrhea completely resolved 48 hours after presentation. The patient consumed a total of twenty-one liters of WHO-OHS and an additional two liters of free water. Final laboratory analysis confirmed infection with Vibrio cholerae, El Tor Ogawa.
THE HISTORY OF CHOLERA
Cholera has been endemic to the Indian subcontinent for millennia. Spread of cholera beyond the Indian subcontinent in 1817 marked the first worldwide pandemic (see Table 1 ). However, compelling descriptions of severe diarrheal diseases consistent with cholera dating from the time of Hippocrates suggest the possibility of an even earlier emergence from Asia [8] .
In 1959, Robert Pollitzer chronicled the first six pandemics [9] . Although reliable serotyping was not available prior to the fifth pandemic, one might presume that the first four pandemics were caused by the same agent ( Table 1 [11] . He subsequently detected kommabazillen in the stools of cholera patients in Calcutta. The name of this bacterium was later changed to Vibrio cholerae, in belated recognition of Filipo Pacini, who had bestowed the latter name on the bacillus he observed in the excreta of cholera victims in Italy thirty years earlier [9] .
Fortunately, even before the etiologic agent was identified, there were those committed to the notion that the spread of cholera could be controlled ". . . not with prayer and fasting, but through disinfection and quarantine.
[C]holera demonstrated forcefully that a disease that could not be cured must be prevented" [12] . From convictions such as these grew institutions like New York City's Metropolitan Board of Health, credited with containing a cholera outbreak in 1866. The association of cholera with unsanitary water and crowded, squalid living conditions has always resulted in a disproportionate representation of the urban poor on its death rolls. Perhaps it was inevitable that so dreadful a scourge -one that generally spared the wealthy and refined while ravaging the 
NORMAL INTESTINAL PHYSIOLOGY
Under normal circumstances, the human gastrointestinal tract can absorb more than 90 percent of the water and ions presented to it. To appreciate fully the pathophysiology of cholera, a brief review of normal water and solute handling by the intestines is helpful.
Water: The healthy small intestine is able to absorb about 7 -8.5 liters of the nine liters that enters it daily, leaving an ileocecal flow rate of 0.5-2 Il/day. It is important to remember that in the small intestine, mature epithelial cells near the tips of the villi are engaged in net absorption, while the less mature cells in Lieberkiihn's crypts function in the net secretion of water and electrolytes. Typically, only about 600 ml of fluid is presented to the colon per day, of which 500 ml are absorbed, leaving the 100 ml contained in the average daily fecal weight of 150 g. Therefore, one functional definition of diarrhea is an average daily fecal weight exceeding 200 g. Since the colon is capable of absorbing 4 to 6 liters of water per day, the 500 ml absorbed represents about 10 percent of the colon's absorptive capacity.
Fluid transport in the small intestine generally results from the passive movement of water across epithelial membranes driven by osmotic and hydrostatic pressures. In the absence of food, ions are the most important contributors to osmotic pressure in the lumen. Since the cells of the small intestine are relatively permeable (leaky), luminal fluid generally remains isotonic with plasma. Because most water absorption occurs in the absence of a transmucosal osmotic gradient, any increase in the osmotic content of the lumen will tend to reduce water absorption and lead to diarrhea. Since 60 to 90 percent of stool weight is water, diarrhea is mainly due to excess fecal water.
Sodium: Sodium is actively absorbed throughout the small intestine, the site most affected in cholera. The favorable electrochemical gradient (negative membrane potential and low intracellular [Na]) allows sodium to enter the cell across the apical brush border, and exit across the basolateral membrane via the Na, K ATPase pump. The net rate of Na+ absorption is highest in the jejunum, where it is enhanced by the presence of glucose, galactose, and neutral amino acids via Na+-sugar cotransport. Indeed, the identification of Na+-coupled cotransport systems stands as one of the most important medical discoveries of this century, since these processes form the basis of oral rehydration therapy used in many parts of the world. The net rate of Na+ absorption is smaller in the ileum due to a lower density of cotransporter proteins.
Potassium: The movement of potassium in the small intestine is usually in the direction of absorption. As It is important to emphasize that since the fluid loss in cholera is essentially isotonic, "dehydration" is not the problem; rather the patient becomes severely volume-depleted. Conceptually, it is absolutely critical to distinguish hypovolemia (loss of salt in isotonic proportions) and dehydration (loss of solute-free water) [14] . Hypovolemia is assessed clinically by physical exam and does not require any laboratory tests, and the diagnosis of salt (volume) depletion implies the life-saving therapy of isotonic salt (volume) repletion. In contrast, "dehydration" implies solutefree water loss, or hypertonicity, which is a laboratory diagnosis.
Chloride secretion
The transport function of epithelia is inextricably linked to the polarized distribution of transport elements in the apical and basolateral membranes of epithelial cells (Figure 2) [18] , since an increase in transport activity requires an increased turnover of the Na,K-ATPase pump, which tends to lower intracellular ATP levels.
Therefore, the development of hypokalemia enhances the secretion of C1-into the lumen. This addition of Cl-to the lumen then provides both an electrical driving force for the paracellular movement of Na+ and an osmotic driving force for water to go into the lumen. The driving force for water flow into the lumen subsists when the luminal fluid becomes isoosmotic, which explains why the secretory diarrhea of cholera is essentially isotonic. To make matters worse, the increasing water content of the lumen "dilutes" the luminal [ 
Cholera toxins
It is not an overstatement to say that the entire clinical syndrome of cholera is due to the action of the cholera toxin on intestinal epithelial cells. Vibrio cholerae is a non-invasive, aerobic, gram-negative bacillus that produces the choleragen, the cholera toxin (CTX). The organism attaches to the intestinal mucosa via various surface adhesion components, such as toxin coregulated pili (tcpA) [19] . The most sensitive regions are in the duodenum and upper jejunum; the ileum is less affected. The organism does not invade the mucosal surface, and bacteremia is virtually never seen. CTX is cytotonic rather than cytotoxic, as it disrupts intracellular processes but does not directly cause cell death.
Although Koch identified Vibrio cholerae as the etiologic agent of cholera, and first proposed that the disease was toxin-mediated in 1884 [10] , CTX has only been characterized in the latter half of this century. In 1959, De showed that inoculation of ligated segments of rabbit small intestine with the sterile and bacteria-free filtrate from cultures of Vibrio cholerae caused marked distension due to the secretion of isotonic fluid [20] . No distension developed in the ligated segments from the same rabbits injected with control medium. This was the first convincing demonstration that Vibrio cholerae must be elaborating a soluble factor that itself is capable of mediating the disease.
The toxin satisfies all of "Koch's postulates," since the toxin: (1) is present in those affected and absent in healthy individuals, (2) can be isolated from infected patients (in this case, from their stool) and produced in culture, (3) is able to cause disease when reinoculated into susceptible hosts from pure culture, and (4) can be reisolated from the experimentally infected host [21] .
The precise mechanism of action is still under investigation, but several studies have yielded information on both its structure [22, 23] and action [24, 25, 26] . There seems to be a differential effect of the toxin on the enterocytes: it exerts a direct stimulatory effect on the secretory crypt cells, and an anti-absorptive effect on the villous cells, which both favor net secretion. Fortunately, the decrease in absorption is much less than the increase in secretion, making oral rehydration therapy (ORT) possible (vida infra). The colon is usually in a state of absorption since it is relatively insensitive to the toxin, but its absorptive capacity is quickly overcome in this "overflow" diarrhea.
The crystal structure of CTX was recently solved [22] , and it closely resembles the heat-labile enterotoxin from Escherichia coli, LT [27] . Both are heterotrimeric complexes, comprised of a pentameric arrangement of five B subunits within which the wedge-shaped A subunit is loosely held [28] . Choleragenoid, the B subunit pentamer of cholera toxin, directs the enzymatic A subunit to its target by binding to the GM1 gangliosides exposed on the luminal surface of intestinal epithelial cells [29, 30, 31] . Interestingly, the two enterotoxins share approximately 80 percent sequence homology, but the other 20 percent may be the difference between a self-limited disease and death. The most significant difference between the two toxins is the carboxyl terminus of the A2 chain, which helps to tether the A subunit above the plane defined by the five B subunits. Apparently, it is differences such as these that lead to the production of much higher levels of cAMP with CTX than with LT.
The A subunit is the active component of the toxin [26] . It is thought that the entire A subunit (or a portion of it) gains entry to the cell through the ring of the B subunits on the apical membrane [32] . The Al peptide, the active fragment of the A subunit cleaved by proteolysis, binds to NAD inside the cell [33, 34] . The toxin subunit then catalyzes the addition of an ADP-ribose from NAD to the G protein that activates adenylyl cyclase, Gs [17, 35, 36] . The cAMP produced activates the cAMP-dependent protein kinase (PKA), whose catalytic subunit then phosphorylates apical membrane chloride channels. There is some evidence that other proteins are also ADP-ribosylated, but the significance of these other additions has not yet been determined [37] .
Normal physiology of G-proteins
The signal transduction mechanism involves heterotrimeric guanine nucleotide binding (G) proteins comprised of an a subunit, and a Py complex (see reviews [38, 39, 40] ). Typically, a first messenger (e.g., a hormone) binds to a membrane receptor, activating a G protein within the membrane. The a-subunit of the activated G protein then exchanges GTP for GDP and dissociates from the fry complex. This activated a-subunit directly interacts with an effector molecule or enzyme such as adenylyl cyclase.
One of the remarkable features of the a-subunit is its intrinsic GTPase enzymatic activity, providing an auto-negative feedback mechanism for regulated deactivation [41] . Once the GTP is hydrolyzed to GDP, the a-subunit may re-associate with the fy complex, thereby turning off the functional activity of the effector molecule.
Cholera toxin and G Proteins
Cholera toxin activates adenylyl cyclase in at least three ways through the ADP-ribosylation of the a-subunit [23, 42] . First, ADP-ribosylation reduces the inherent GTPase activity of the a-subunit by a factor of one hundred, resulting in a tremendous increase in the production of cAMP [43, 44] . Second, the addition of ADP-ribose facilitates the physical dissociation of the Py complex from the a-subunit [45] . Finally, the ADP-ribosylation by cholera toxin prevents the dissociation of the a-subunit from the activated cyclase, keeping the enzyme locked in its active state [42, 46] .
The ADP-ribosylation by cholera toxin requires the presence of separate ADP-ribosylation factors, or ARFs [47, 48] . ARFs are GTP-binding proteins, normally present in cells, that function in conjunction with the cholera toxin to increase the level of adenylyl cyclase activity [49] . ARFs appear to be allosteric activators of the Al peptide, interacting directly with the toxin to stimulate its activity in vivo [50, 51, 52] . Currently three highly conserved classes of these factors have been identified, and different ARFs may be have optimal activity under different environmental conditions [53, 54] .
Thus, the result of the action of cholera toxin is an elevation of cAMP to pathologically high intracellular levels through a G protein mediator. CTXinduced elevations in cAMP lead to an abnormally high apical membrane chloride conductance, due to opening of the CFTR chloride channels. Chloride can then move down its concentration gradient, spilling from the cell in abnormally high quantities. Due to the resultant electronegative lumen, sodium is secreted via a paracellular pathway. This osmotic gradient drives water flow into the lumen, with the net effect being the secretion of massive amounts of isotonic fluid.
Cholera toxin exerts additional effects, separate from the adenylyl cyclase system. For instance, CTX also triggers intestinal enterochromaffin cells to release serotonin [55] . Serotonin may contribute to heightened gastrointestinal secretion by serving as a excitatory neurotransmitter of intramural neurons within the enteric nervous system [56, 57] . VIP-containing neurons may serve as the effectors of vasodilata-tion, increasing mucosal perfusion and, as a result, intestinal secretion [58, 59] .
Furthermore, Vibrio cholerae produces other toxins in addition to CTX [60] . Zonula occludens toxin (Zot) increases intestinal permeability by weakening the tight junctions that maintain the integrity of the epithelial sheet [61] . Zot interacts with specific cell receptors, reversibly affecting the actin elements of the cytoskeleton, allowing increased loss of ions into the intestinal lumen [62] . Accessory cholera enterotoxin (Ace) also contributes to secretory diarrhea, possibly by opening channels and increasing the potential difference across the apical membrane [63] . Pathogenic strains of Vibrio cholerae may also produce a sodium channel inhibitor [64] . These additional toxins have a supplementary role to CTX in the pathogenesis of secretory diarrhea in cholera.
CHOLERA AND THE HETEROZYGOTE ADVANTAGE HYPOTHESIS
The impact of cholera goes well beyond the clinical syndrome of cholera gravis. To the present day, cholera continues to challenge definitions of disease and the underlying mechanisms that maintain diseases within the human population. On a fundamental level, the most important question is why certain diseases (like cystic fibrosis) exist at all, and to answer it, we are again confronted with the problem of cholera.
In select circumstances, there can be a theoretical advantage to heterozygosity for a damaging trait, when this combination of alleles protects the carrier from another severe disorder. In perhaps the best known example, heterozygotes for the abnormal protein Hemoglobin S do not have sickle cell anemia, but are protected to a certain degree against malaria [65] . Thus, there exists a "heterozygote advantage" that maintains the frequency of this otherwise deleterious recessive gene in the general population.
A similar advantage has been hypothesized for the diseases of cholera and cystic fibrosis (CF) [66, 67, 68] . In CF, the apical chloride channel (CFTR) is hyperactive or inactive, preventing the direct transport of chloride across cellular membranes [69, 70] . This homozygous recessive disorder occurs at a frequency of one in 2500 Caucasian live births, an alarmingly high rate given the severity of the disease [71] . This high rate is inadequately explained by the effects of genetic mutation or by a fertility difference of the carriers [72, 73] .
Heterozygotes for CF have some abnormal channels due to the mutant gene, as well as normal channels due to the wildtype gene. In the absence of infection or severe stressors, the heterozygote would suffer few clinically evident abnormalities, due to the presence of the subset of normally functioning channels [74] . However, it is possible that when heterozygotes for CF become infected with Vibrio cholerae, the increase in apical chloride conductance is blunted, thereby attenuating the massive loss of salt associated with those cholera victims having a full complement of normal CFTR channels [75, 76] . A recent experiment confirmed this hypothesis using transgenic mice, showing that chloride secretion was directly correlated to the number of CFTR alleles [77] . However, other experiments have not provided as conclusive data [78] .
Cholera has remained a scourge throughout the latter half of the last century. Considering the time scale necessary for adaptation, not enough time has passed to remove the allele from the gene pool [2] . Thus, it is possible that CF continues to exist in the human population because heterozygosity for this disorder is to some extent protective against cholera. For this reason alone, the identification of sodium-coupled epithelial cotransport processes was a major medical breakthrough. Although Reid had provided experimental evidence supporting the transport of sugars against a concentration difference at the turn of the century [79] , the dependence on luminal sodium was first observed by Riklis and Quastel in the late 1950s [80] . In the early 1960s, Crane and colleagues advanced these ideas and showed that sodium-dependent sugar cotransport occurred in the luminal brush border of small intestinal epithelial cells [81, 82] . The first of the family of sodiumglucose transporters was subsequently cloned from rabbit small intestine by Wright and coworkers in 1987 [83] .
TREATMENT
Normally the sodium-coupled transporters utilize the large electrochemical gradient of sodium to drive absorption of sugars and other nutrients (e.g., amino acids). Although cholera toxin biases the system strongly in the direction of secretion, reabsorptive processes are largely left intact. In fact, one study involving total intestinal perfusion with cholera toxin in human volunteers demonstrated a doubling of net sodium cotransport after exposure to CT [84] . Therapy with ORS takes advantage of cotransport, by using sugar to drive the reabsorption of salt. This attempt at restoring balance to a hyperactive secretory system can be lifesaving.
To stop the losses in cholera, the source of the infection must be eliminated. Fortunately, the Vibrio infection itself is self-limited; that is, bacteria do not remain active in the intestinal tract for extended periods of time. Although antibiotics may decrease the severity of the clinical symptoms or otherwise diminish the course of the illness, in most cases they are not essential to the treatment of the disorder. Therefore, in developing countries or in those in which medicine is in short supply, a regimen of ORS will permit the survival of the vast majority of those infected [85] , as in case scenario [3] .
In the present day, most physicians would begin treatment with intravenous isotonic saline, bicarbonate replacement, and antibiotics (tetracycline, doxycycline, or ciprofloxacin [86] 
